Researchers from University of Southern Denmark Provide Details of New Studies and Findings in the Area of Insurance Economics (Comparative…

Researchers from University of Southern Denmark Provide Details of New Studies and Findings in the Area of Insurance Economics (Comparative evaluation of the CerTest VIASURE flu A, B & RSV real time RT-PCR detection kit on the BD MAX system ...)

By a News Reporter-Staff News Editor at Virus Weekly -- Current study results on Influenza have been published. According to news originating from Odense, Denmark, by NewsRx correspondents, research stated, "Diagnosing of influenza rapidly and accurately helps clinicians to initiate appropriate treatment options and isolation protocols. Unnecessary antimicrobial treatment and laboratory testing can also be reduced."

Our news journalists obtained a quote from the research from the University of Southern Denmark, "Assess commercial alternatives to in-house assays that may not only reduce laboratory technician 'hands on' time but also the laboratory turnaround time is of interest. We evaluated the performance of the VIASURE Flu A, B & RSV Real Time RT-PCR Detection Kit (CerTest Biotec) for detecting Influenza A and B viruses. During the 2016/17 influenza season 532 clinical samples were tested with the VIASURE assay on the BD MAX ™ system versus an in-house real time RT-PCR assay with discrepant results resolved by a real time RT-PCR assay at a national reference laboratory. The VIASURE assay on the BD MAX showed a sensitivity of 99.5% (95% CI: 97.3-100) and a specificity of 99.1% (95% CI: 97.4-99.8) for detection of Influenza A virus. The positive predictive and negative predictive values were 98.5% (95% CI: 95.8-99.7) and 99.7% (95% CI: 98.3-100) respectively. Influenza B virus detection could not be evaluated due to a low positivity rate. The BD MAX platform offered the flexibility of several daily runs, shorter hands-on-time and shorter turnaround time than the in-house assay."

According to the news editors, the research concluded: "The VIASURE assay on the BD MAX performed well and is now implemented in our clinical laboratory."

For more information on this research see: Comparative evaluation of the CerTest VIASURE flu A, B & RSV real time RT-PCR detection kit on the BD MAX system versus a routine in-house assay for detection of influenza A and B virus during the 2016/17 influenza season. Journal of Clinical Virology, 2018;99-100():35-37. Journal of Clinical Virology can be contacted at: Elsevier Science Bv, PO Box 211, 1000 Ae Amsterdam, Netherlands. (Elsevier - www.elsevier.com; Journal of Clinical Virology - www.journals.elsevier.com/journal-of-clinical-virology/)

The news correspondents report that additional information may be obtained from T.V. Sydenham, Univ Southern Denmark, Dept. of Clin Res, Res Unit Clin Microbiol, Fac Hlth Sci, DK-5000 Odense C, Denmark. Additional authors for this research include M. Bek-Thomsen, S.D. Andersen, B. Kolmos, E.S. Marmolin, R. Trebbien and J.K. Moller (see also Economics - Insurance Economics).

The direct object identifier (DOI) for that additional information is: https://doi.org/10.1016/j.jcv.2017.12.010. This DOI is a link to an online electronic document that is either free or for purchase, and can be your direct source for a journal article and its citation.

Keywords for this news article include: Odense, Denmark, Europe, Influenza, University of Southern Denmark.

Our reports deliver fact-based news of research and discoveries from around the world. Copyright 2018, NewsRx LLC